InvestorsHub Logo
Followers 27
Posts 2018
Boards Moderated 0
Alias Born 09/18/2009

Re: stinging123 post# 25920

Tuesday, 09/09/2014 11:08:35 AM

Tuesday, September 09, 2014 11:08:35 AM

Post# of 39184
Dont forget this...

Emesyl was developed by Dr. Charles Hensley who also developed Zicam, a homeopathic cold remedy that has been around since the mid-1990s. If the drug could have a fraction of the success of Zicam then investors in Itonis would stand to make tremendous gains.

With any company of this size there are considerable risks but the upside is huge. Matrixx Initiatives was the company that owned and marketed Zicam. In 2011 Matrixx was purchased by H.I.G. Capital for $8.75 a share, or a little over $75 million. A fraction of such a payoff might be worth the risk for this company.



LOVE ITNS